Effectiveness of β-blockade in experimental chronic aortic regurgitation

Circulation

Volumn 110, Issue 11, 2004, Pages 1477-1483

  Plante, Eric ^a   Lachance, Dominic ^a   Gaudreau, Martin ^a   Drolet, Marie Claude ^a   Roussel, Élise ^a   Arsenault, Marie ^a   Couet, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Adrenergic; Aortic; Beta; Echocardiography; Insufficiency; Receptors; Regurgitation; Valve

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE 2; G PROTEIN COUPLED RECEPTOR KINASE 2; MESSENGER RNA; METOPROLOL TARTRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE REGURGITATION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTIC VALVE INSUFFICIENCY; CATECHOLAMINES; CELL SIZE; CHRONIC DISEASE; DRUG EVALUATION, PRECLINICAL; FIBRONECTINS; HEART RATE; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; MALE; METOPROLOL; MYOCYTES, CARDIAC; ORGAN SIZE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RNA, MESSENGER; STROKE VOLUME; UP-REGULATION; VENTRICULAR REMODELING;

EID: 4544219822     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000141733.55236.9D     Document Type: Article

References (32)

1. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis. 1998;7:672-707.
2. Tomos MP, Olona M, Permanyer-Miralda G, et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am Heart J. 1995:130:333-339.
3. Suzuki M, Yoshikawa T, Wainai Y, et al. Beta-blockade prevents ventricular failure following aortic regurgitation in rabbits. Cardiology. 1997: 88:418-424.
4. Yoshikawa T, Handa S, Nagami K, et al. Effect of the angiotensin- converting enzyme inhibitor alacepril on ventricular function and beta-adrenoceptor number in rabbits with aortic regurgitation. Jpn Heart J. 1995;36:91-100.
5. Yoshikawa T. Handa S, Suzuki M, et al. Abnormalities in sympatho-neuronal regulation are localized to failing myocardium in rabbit heart. J Am Coll Cardiol. 1994;24:210-215.
6. Yoshikawa T, Handa S, Yamada T, et al. Sequential changes in sympatho-neuronal regulation and contractile function following aortic regurgitation in rabbit heart. Eur Heart J. 1993;14:1404-1409.
7. Anzai T, Yoshikawa T, Baba A, et al. Myocardial sympathetic denervation prevents chamber-specific alteration of beta-adrenergic transmembrane signaling in rabbits with heart failure. J Am Coll Cardiol. 1996;28:1314-1322.
8. Uematsu T, Yamazaki T, Matsuno H, et al. A simple method for producing graded aortic insufficiencies in rats and subsequent development of cardiac hypertrophy. J Pharmacol Methods. 1989;22:249-257.
9. Yamazaki T, Uematsu T, Mizuno A, et al. Alterations of cardiac adrenoceptors and calcium channels subsequent to production of aortic insufficiency in rats. Arch Int Pharmacodyn Ther. 1989;299:155-168.
10. Cartagena G, Sapag-Hagar M, Jalil J, et al. Changes in beta-adrenergic receptors of rat heart and adipocytes during volume-overload induced cardiac hypertrophy. Int J Clin Pharmacol Ther Toxicol. 1993;31: 198-203.
11. Xiong L, Bouanani NE, Su JB, et al. Propranolol therapy in experimental heart failure in rabbits improves cardiac response to catecholamines without beta-adrenoceptor up-regulation. Fundam Clin Pharmacol. 1995; 9:522-530.
12. Wright AJ. Hudlicka O, Brown MD. Beneficial effect of chronic brady-cardial pacing on capillary growth and heart performance in volume overload heart hypertrophy. Circ Res. 1989;64:1205-1212.
13. Nemoto S, Hamawaki M, De Freitas G, et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol. 2002;40:149-154.
14. Tsutsui H, Spinale FG, Nagatsu M, et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994:93:2639-2648.
15. Plante E, Couet J, Gaudreau M, et al. Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats. J Card Fail. 2003;9:128-140.
16. Plante E, Gaudreau M, Lachance D, et al. Angiotensin converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation. Can J Physiol Pharmacol. 2004;82:191-199.
17. Arsenault M, Plante E, Drolet MC, et al. Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis. 2002; 11:128-134.
18. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation. 1991;84(suppl 1):1-280-1-287.
19. Bélanger MM, Roussel E, Couet J. Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells. Anticancer Drugs. 2003;14:281-287.
20. Krum H. Beta-blockers in chronic heart failure: what have we learned? What do we still need to know? Curr Opin Pharmacol. 2003;3:168-174.
21. Nishimura H. Yoshikawa T, Anzai T, et al. Baroreceptor sensitivity during the compensatory phase of left ventricular overloading. Jpn Circ J. 1998:62:773-778.
22. Guzzetti S, Mennini T, Cagnotto A, et al. Myocardial beta-adrenergic and muscarinic receptor density in cardiac pressure or volume overload. J Mol Cell Cardiol. 1998;30:2095-2102.
23. Dzimiri N, Moorji A, Kumar M, et al. Comparison of the effect of left ventricular volume and pressure overload on beta-adrenoceptor density in left heart valvular disease. Int J Cardiol. 1996;53:109-116.
24. Imamura Y, Ando H, Mitsuoka W, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594-1599.
25. Matsuyama K, Ueda Y, Ogino H, et al. Beta-blocker therapy in patients after aortic valve replacement for aortic regurgitadon, Int J Cardiol. 2000;73:49-53.
26. Moncada GA, Hashimoto Y, Kobayashi Y, et al. Usefulness of beta blocker therapy in patients with Takayasu arteritis and moderate or severe aortic regurgitation. Jpn Heart J. 2000;41:325-337.
27. Hashimoto Y, Tanaka M, Hata A, et al. Four years follow-up study in patients with Takayasu arteritis and severe aortic regurgitation; assessment by echocardiography. Int J Cardiol. 1996;54(suppl): S173-S176.
28. Petrofski JA, Koch WJ. The beta-adrenergic receptor kinase in heart failure. J Mol Cell Cardiol. 2003;35:1167-1174.
29. Choi DJ, Koch WJ. Hunter JJ, et al. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-17229.
30. Ping P, Anzai T, Gao M, et al. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol. 1997;273:H707-H717.
31. Vinge LE, Oie E, Andersson Y, et al. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol. 2001;281:H2490-H2499.
32. Morita H, Suzuki G, Mishima T, et al. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Cardiovasc Drugs Ther. 2002;16:443-449.